Hadar Mirit Horenshtein
CIK: 0002033245
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
SLXN
Silexion Therapeutics Corp
Officer
Discretionary Trading P&L
Holdings
About Horenshtein Hadar Mirit
Horenshtein Hadar Mirit (SEC CIK 0002033245) files insider reports with the SEC as CFO and Secretary of Silexion Therapeutics Corp (SLXN).
Signal8 holds 2 ownership filings by Horenshtein Hadar Mirit, all Form 4s, filed between Feb 23, 2026 and Jun 8, 2026. Those filings report 2 transactions, from Feb 20, 2026 to Jun 4, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Horenshtein Hadar Mirit's filings is in HERZLIYA.
Recent filings by Horenshtein Hadar Mirit
Other insiders filing for Silexion Therapeutics Corp (SLXN)
- Shirvan Mitchell, CSO and CDO
- Hadar Ilan, Chairman and CEO
- Noy Shlomo, Director
- Alon Ruth, Director
- Abramov Dror Yosef, Director
- Peled Amnon, Director